obesity glp-1 news today Study: US rates are dropping as use increases New global position statement 🌍

Related products Log in

According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025

Preliminary experiments on murine models suggest that Ipamorelin may have mitigated the loss of muscle strength, which can occur in artificially-induced catabolic conditions

Lipo-B (MIC) Injections Lipo-B (MIC) injections are formulated with a blend of lipotropic agents that assist in removing fat from the body, support the livers function, and increase metabolism